Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 2 Jan 2002 16:16:44 -0800
Received: from corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 2 Jan 2002 18:16:42 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a500080c0a86ee241c@corp.enron.com> for <mwhitt@exchange.enron.com>;
 Wed, 2 Jan 2002 18:16:08 -0600
Received: from nm-dkbg-446d.adsl.wanadoo.nl (nm-dkbg-446d.adsl.wanadoo.nl [212.129.196.109])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl66667
        for <MWHITT@ENRON.COM>; Wed, 2 Jan 2002 18:14:24 -0600 (CST)
Received: from lisa.bcwire.com ([207.35.205.43])
          by flake.aeroplanemodels.com
          (InterMail vK.4.04.00.03 454-341-539-20033389 license 9my938nf7278o0ra4p2mxn9613n2rhk1)
          with SMTP
          id <20044874204688.QEIT6361.flake@lisa.bcwire.com>
          for <MWHITT@ENRON.COM>; Wed, 2 Jan 2002 23:23:12 -0200
Received: from mail pickup service by flake.aeroplanemodels.com with Microsoft
 SMTPSVC; Wed, 2 Jan 2002 18:20:12 -0700
Date: Thu, 3 Jan 2002 03:16:12 +0200
From: "Berta Matos" <waape@betsybauer.com>
Subject: Leading authOrity On |Ow priced st0cks
To: <MWHITT@ENRON.COM>
References: <GGK14DQFY7C6TFRC@bcwire.com>
In-Reply-To: <GGK14DQFY7C6TFRC@bcwire.com>
Message-ID: <910035453955.EXQ66262@ehrlich.aeroplanemodels.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,000,O00 EST
Current Price: 0.O8
2004 Success |ead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9O01 industria| certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of phenolic secondary 
metabo|ites of plants that inc|ude more than 2,0O0 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeabi|ity of the wa|ls of the blood vessels including capil|aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2OO4-20O5 are more then  $100 milli0n USD

Further deve|opments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny StOcks are considered highly speculative and may be unsuitable 
for all but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3O00 do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and shou|d not be used as investment advice.  
 
If you wish to stop future mailings, or if you fee| you have been
wrongfu||y p|aced in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck73 @ yahoo.com

